These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 26292621)

  • 1. Functional autoantibodies in systemic sclerosis.
    Günther J; Rademacher J; van Laar JM; Siegert E; Riemekasten G
    Semin Immunopathol; 2015 Sep; 37(5):529-42. PubMed ID: 26292621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on autoantibodies in systemic sclerosis.
    Walker JG; Fritzler MJ
    Curr Opin Rheumatol; 2007 Nov; 19(6):580-91. PubMed ID: 17917539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmunity in scleroderma: the origin, pathogenetic role, and clinical significance of autoantibodies.
    Harris ML; Rosen A
    Curr Opin Rheumatol; 2003 Nov; 15(6):778-84. PubMed ID: 14569210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-topoisomerase I autoantibodies in systemic sclerosis.
    Czömpöly T; Simon D; Czirják L; Németh P
    Autoimmun Rev; 2009 Jul; 8(8):692-6. PubMed ID: 19393194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Novel autoantibodies in inflammatory myopathies and systemic sclerosis].
    Ribi C
    Rev Med Suisse; 2015 Jan; 11(456-457):25-9. PubMed ID: 25799647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenic autoantibodies in systemic sclerosis.
    Gabrielli A; Svegliati S; Moroncini G; Avvedimento EV
    Curr Opin Immunol; 2007 Dec; 19(6):640-5. PubMed ID: 18083509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies to the epidermal growth factor receptor in systemic sclerosis, lupus, and autoimmune mice.
    Planque S; Zhou YX; Nishiyama Y; Sinha M; O'Connor-Mccourt M; Arnett FC; Paul S
    FASEB J; 2003 Feb; 17(2):136-43. PubMed ID: 12554692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-CENPI autoantibodies in scleroderma patients with features of autoimmune liver diseases.
    Hamdouch K; Rodríguez C; Pérez-Venegas J; Rodríguez I; Astola A; Ortiz M; Yen TJ; Bennani M; Valdivia MM
    Clin Chim Acta; 2011 Nov; 412(23-24):2267-71. PubMed ID: 21888900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Autoantibodies in systemic sclerosis (scleroderma)].
    Greenbaum E; Laufer M; Shoenfeld J
    Harefuah; 1993 Mar; 124(6):370-4. PubMed ID: 8388360
    [No Abstract]   [Full Text] [Related]  

  • 10. Autoantibodies against nuclear, nucleolar, and mitochondrial antigens in systemic sclerosis (scleroderma).
    Reimer G
    Rheum Dis Clin North Am; 1990 Feb; 16(1):169-83. PubMed ID: 2406806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells.
    Lunardi C; Bason C; Navone R; Millo E; Damonte G; Corrocher R; Puccetti A
    Nat Med; 2000 Oct; 6(10):1183-6. PubMed ID: 11017152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulatory autoantibodies to platelet-derived growth factor receptors in systemic sclerosis: what functional autoimmunity could learn from receptor biology.
    Dragun D; Distler JH; Riemekasten G; Distler O
    Arthritis Rheum; 2009 Apr; 60(4):907-11. PubMed ID: 19333918
    [No Abstract]   [Full Text] [Related]  

  • 13. Stimulatory autoantibodies to the PDGF receptor: a link to fibrosis in scleroderma and a pathway for novel therapeutic targets.
    Gabrielli A; Svegliati S; Moroncini G; Luchetti M; Tonnini C; Avvedimento EV
    Autoimmun Rev; 2007 Dec; 7(2):121-6. PubMed ID: 18035321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive systemic sclerosis.
    Reichlin M
    Immunol Ser; 1991; 54():275-87. PubMed ID: 1954278
    [No Abstract]   [Full Text] [Related]  

  • 15. The pathogenic role of autoantibodies to nuclear autoantigens in systemic sclerosis (scleroderma).
    Senécal JL; Hénault J; Raymond Y
    J Rheumatol; 2005 Sep; 32(9):1643-9. PubMed ID: 16142854
    [No Abstract]   [Full Text] [Related]  

  • 16. [Progressive systemic sclerosis. Chromosomal instability nd its correlation with the presence of autoantibodies].
    Martínez-Cordero E; Reyes López PA; Vergara MD; Morán Ramón L; Benavides de Larraza G; Kofman de Alfaro S; Katona Salgo G
    Rev Invest Clin; 1985; 37(4):329-35. PubMed ID: 3879371
    [No Abstract]   [Full Text] [Related]  

  • 17. Is scleroderma an autoantibody mediated disease?
    Arnett FC
    Curr Opin Rheumatol; 2006 Nov; 18(6):579-81. PubMed ID: 17053501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An update on autoantibodies in scleroderma.
    Mecoli CA; Casciola-Rosen L
    Curr Opin Rheumatol; 2018 Nov; 30(6):548-553. PubMed ID: 30148799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitope Specificity Determines Pathogenicity and Detectability of Anti-Platelet-Derived Growth Factor Receptor α Autoantibodies in Systemic Sclerosis.
    Moroncini G; Grieco A; Nacci G; Paolini C; Tonnini C; Pozniak KN; Cuccioloni M; Mozzicafreddo M; Svegliati S; Angeletti M; Kazlauskas A; Avvedimento EV; Funaro A; Gabrielli A
    Arthritis Rheumatol; 2015 Jul; 67(7):1891-903. PubMed ID: 25808833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies in systemic sclerosis.
    Steen VD
    Semin Arthritis Rheum; 2005 Aug; 35(1):35-42. PubMed ID: 16084222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.